Carrier peptides deliver nutrients to targeted areas of your body
While GLP-1s may assist with weight management, addressing cortisol and progesterone imbalance is also key to long-term relief
The addition of a candidate targeting glucagon, as well as GLP-1 and GIP, will add important optionality to our clinical pipeline, as we look to develop a broad portfolio of differentiated treatment options that cater to the diverse needs of people living with these highly prevalent diseases, said Martin Holst Lange, executive vice president for Development at Novo Nordisk
Before and after improvements may include brighter skin, a more even complexion, and enhanced skin clarity, but these outcomes are best achieved through medically supervised care
Potential side effects: Ensuring you understand what to expect and how each medication might affect you